Singer D, Salem A, Stempniewicz N, Ma S, et al. The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years. Vaccine 2023 Aug 2:S0264-410X(23)00837-X. doi: 10.1016/j.vaccine.2023.
PMID: 37541822